Ruth Catharina de Lange Davies is Professor of Biophysics at the Norwegian University of Science and Technology. Her research specializes in ultrasound-mediated drug delivery systems, particularly nanoparticle transport mechanisms in tumors and advanced imaging techniques for real-time therapeutic monitoring. Core research domains: Ultrasound-enhanced drug delivery using microbubbles Acoustic Cluster Therapy (ACT) development Intravital multiphoton microscopy techniques Nanoparticle-tissue interactions Hydrogel transport dynamics Her recent publications demonstrate innovative approaches to overcoming biological barriers in drug delivery. Studies utilizing high-speed optical characterization reveal how microbubble composition affects ultrasound-triggered drug release, while intravital microscopy work visualizes real-time drug extravasation dynamics. Molecular dynamics simulations complement experimental findings on ultrasound-enhanced diffusion mechanisms. Davies' team investigates tumor-specific responses to ultrasound interventions, noting significant variations in vascular effects depending on tumor type and microbubble characteristics. This work informs precision applications of acoustic therapies in oncology.
Søren Erik Pischke is a Professor at the Faculty of Medicine, University of Oslo, and a Senior Consultant at the Department of Anaesthesiology and Intensive Care Medicine, Oslo University Hospital. He is a key member of the Norwegian Complement Research Group and leads research on complement-related sterile inflammation. His work integrates clinical practice with translational immunology, focusing on ischemia/reperfusion injury in organ transplantation and critical illness. University: University of Oslo Hospital Affiliation: Oslo University Hospital, Rikshospitalet Research Group: Norwegian Complement Research Group Leadership Role: Topic Leader in Complement-related Sterile Inflammation His research centers on the innate immune system, particularly the complement cascade and Toll-like receptors, in sterile inflammatory conditions such as organ transplantation, myocardial infarction, and sepsis. He utilizes advanced models including human whole blood assays, porcine in vivo models, and ex situ machine perfusion of livers and kidneys. A major focus is on developing dual inhibition strategies targeting complement and TLR pathways to mitigate tissue damage. His group also investigates amyloid fibril-induced complement activation and systemic inflammation post-trauma or infection. His recent publications reveal a consistent trend in understanding complement activation in diverse clinical contexts—from transplant rejection and machine perfusion to sepsis and COVID-19. The articles emphasize biomarker discovery, therapeutic targeting, and real-time monitoring of organ viability, reflecting a strong translational orientation. Prestigious honorary award (2023) Elected to European Complement Network Board (2024) Pischke actively supervises three PhD candidates and one postdoctoral researcher, with additional co-supervision roles. His research is funded by the South-Eastern Norway Regional Health Authority, UiO:LifeScience, the Norwegian Cancer Society, and the Norwegian Research Council. He leads the clinical machine perfusion program for livers at Oslo University Hospital, positioning him at the forefront of innovative transplant medicine. He also contributes to national and international research consortia, including the UiO:LifeScience '3DR' project. His lab is embedded within the Norwegian Complement Research Group, which spans Oslo and Bodø, and collaborates extensively on complement therapeutics and systemic inflammation. The team uses cutting-edge technologies such as microdialysis, tissue CO2 monitoring, and machine perfusion systems to study organ injury and recovery.
Halvor Rollag is a Professor of Medical Microbiology at the University of Oslo's Department of Microbiology. He has held this position since 1993 and is affiliated with Oslo University Hospital. His research focuses on viral infections in immunocompromised patients, antiviral drug development, and the epidemiology of infectious diseases, particularly cytomegalovirus (CMV) and parvovirus B19 in transplant recipients and pregnant women. Education: MD, 1970, University of Erlangen, Germany Ph.D., 1985, University of Oslo Research Interests: Pathogenesis of viral infections in immunosuppressed populations Clinical management of CMV in transplant recipients Maternal-child transmission of CMV/parvovirus Antiviral drug efficacy and resistance Key Findings: Pioneering work on CMV's impact on kidney transplant survival, viral biomarkers for treatment response, and maternal-fetal transmission pathways. His studies have redefined clinical management strategies for post-transplant CMV infections. Awards: 2008 Honorary Prize from Norwegian Medical Association for contributions to Microbiology & Infectious Diseases Collaborations: Works with Oslo University Hospital researchers and international partners in Canada, USA, UK, and New Zealand on viral pathogenesis and clinical virology. Labs/Teams: Active in the ClinVir (Clinical Virology) research group at UiO.
Steven Ray Haakon Wilson is a Professor in the Department of Chemistry at the University of Oslo, specializing in analytical chemistry with a focus on chromatography and mass spectrometry (LC-MS). He leads research groups in the Hybrid Technology Hub (Center of Excellence) and the Norwegian Network of Advanced Proteomics Infrastructure (NAPI). His work emphasizes LC-MS applications in organoid studies, diagnostics (proteomics/metabolomics), and innovation projects for chemical analysis commercialization. Collaborations include SINTEF, Copenhagen University, and industry partners like Novo Nordisk. He teaches analytical chemistry and biochemistry, having won multiple teaching awards. Additionally, he is an active science communicator through media platforms. Research interests span LC-MS method development, organoid-based systems, and translational technologies for healthcare. Recent work includes FDA-validated self-cleaning LC-MS systems and integrative 'organ-in-a-column' platforms. His innovation projects target technology commercialization via partnerships with Inven2 and UiO Growth House. Collaborations extend across academia and industry, supported by grants from the Norwegian Research Council and SPARK Norway. Teaching contributions are complemented by leadership roles in science outreach and public engagement.
Erik Knutsen is an Associate Professor at the Institute of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway. He holds a PhD in Medical Biology and a Master’s in Molecular Biotechnology. He currently serves as the Study Program Leader for the Bachelor program in Biomedicine and teaches cellular biology at undergraduate and graduate levels. His research is centered on breast cancer metastasis, focusing on molecular mechanisms such as epithelial-mesenchymal transition (EMT), tumor microenvironment, non-coding RNAs, and single-cell sequencing. He leads a major project using single-cell RNA-seq to subclassify breast cancer cells in lymph nodes for improved diagnosis and personalized treatment. His goal is to prevent overtreatment and understand tumor dormancy and recurrence. Erik’s recent publications span high-impact journals like Nature , PNAS , and Journal of Clinical Investigation , with research themes in bioinformatics, CRISPR/Cas, serglycin, miRNA regulation, and liquid biopsies. His work often involves large-scale computational analysis and collaboration with clinicians, bioinformaticians, and molecular biologists. Scientific Awards: No specific awards listed in the provided text. Erik is currently supervising two PhD students and one master student as main supervisor, and one PhD student as co-supervisor. He has previously supervised multiple master’s, bachelor’s, and Erasmus+ trainee students. His research is supported by strong national and international collaborations, including work with George A. Calin at MD Anderson. He has led projects on functional RNA profiling, miRNA variations, and transcriptome analysis in cancer. He is based in Tromsø and actively contributes to both research and education in molecular oncology.
Lars Herfindal is a Professor at the University of Bergen, affiliated with Clinical Institute 2. His research focuses on nanomedicine, anti-cancer therapies, and the discovery of bioactive compounds from natural sources. He leads projects on drug delivery systems, particularly liposomal formulations and cyclodextrin nanoparticles, emphasizing selective cytotoxicity in leukemia and other cancers. Herfindal has pioneered the exploration of cyanobacterial and plant-derived natural products for their anticancer and antimicrobial properties. He collaborates extensively, supervising students in pharmacology, biochemistry, and biomedical engineering. His work integrates zebrafish models, high-content imaging, and nanotechnology to advance personalized cancer treatments. Notable contributions include studies on iodinin, phenazine derivatives, and graphene-based drug carriers. Herfindal’s research also addresses complement system activation by monoclonal antibodies and the role of AXL in breast cancer stemness. He is actively involved in drug repurposing, such as chlorpromazine encapsulation, and has developed novel software tools for in vivo cell analysis. Education: PhD in Biomedicine (2006, University of Bergen) Key Research Themes: Leukemia treatment, natural product drug discovery, nanocarrier systems, marine biotechnology. Herfindal’s lab collaborates with institutions like Haukeland University Hospital and University of Helsinki, advancing translational research in oncology and pharmacology. His publications span over 150 peer-reviewed articles, emphasizing interdisciplinary approaches to combat chemoresistance and improve therapeutic outcomes.
Henriette Aksnes is a Researcher at the Department of Biomedicine, University of Bergen (UiB), and a Group Leader for MemBrain. She serves as Scientific Director for light microscopy at the Molecular Imaging Center (MIC) and contributes to Systems Biology and Translational Cell Signaling research. Her expertise bridges Molecular Cell Biology and Molecular Neuroscience (MSc, PhD). Research Focus: Protein N-terminal acetylation (NAT enzymes) in neurodegenerative diseases (e.g., Parkinson’s) and actin cytoskeleton regulation in cancer metastasis. Key Projects: Mechanistic studies of NAA60 in brain calcification, NAA80’s role in Golgi integrity, and collaborations with UCL neurologists. Scientific Awards: Starting Grant (Trond Mohn Foundation), Meltzer Award for Young Researchers, Falch Junior Award, ZONA Award for Best PhD 2014, and Best Paper of the Year (2018). Student Supervision: Mentored over 20 MSc/PhD candidates, including Anton R. Melbye, Alessia Caiella, and Åse K. Bekkelund. Co-hosted the 2022 EMBO conference on Protein Termini. Outreach: Featured in FEBS’ Women in Science eBook, interviewed in NatureVolve and Incyte blog, and contributed to popular science articles on neurodegeneration and cancer cell dynamics.
Jorunn Pauline Cavanagh is an Associate Professor at UiT The Arctic University of Norway's Department of Clinical Medicine, where she leads research in the Paediatric Infection Group. Her work focuses on pediatric infections, particularly those caused by coagulase-negative staphylococci, biofilms, and antibiotic resistance. She discovered the novel bacterial species Staphylococcus borealis and leads the OPTIMIST project investigating mastitis in nursing mothers. Her research spans antimicrobial peptides, bacterial membrane models, and gut microbiome dynamics in pediatric populations. Key interests include: Developing bacteriocin-based therapies against antibiotic-resistant biofilms Characterizing virulence mechanisms in Staphylococcus haemolyticus Optimizing diagnostics for neonatal infections Cavanagh's recent publications (2021-2025) predominantly explore: Novel antimicrobial agents and surface treatments Bacterial extracellular vesicle applications Gut resistome development in early life Immunomodulation strategies for neonatal inflammation She supervises bachelor's, master's, and PhD students while coordinating projects on mastitis identification and bacterial membrane modeling.
Ellen Dalen Arnstad is a medical researcher at the Norwegian University of Science and Technology (NTNU), Faculty of Medicine and Health Sciences, Department of Clinical and Molecular Medicine. She is a key contributor to the Nordic Juvenile Idiopathic Arthritis (JIA) cohort study, collaborating with researchers across multiple Nordic countries including Norway, Sweden, Denmark, and Finland. Her work focuses on long-term outcomes of JIA patients transitioning into adulthood. Dr. Arnstad's primary research interests center on juvenile idiopathic arthritis, with specific focus on long-term disease outcomes , pain assessment , fatigue measurement , quality of life in young adults with JIA, and disease activity trajectories . Her work employs both clinical assessments and quantitative sensory testing to understand the persistent effects of JIA well into adulthood. Analysis of her publication record from 2018-2024 reveals a consistent focus on longitudinal studies of JIA patients, particularly examining how childhood disease characteristics predict adult outcomes. Her research frequently investigates biomarkers, pain sensitivity, and quality-of-life measures, with a strong emphasis on population-based cohort studies that track patients for 17-18 years after disease onset. Dr. Arnstad completed her doctoral thesis titled "Pain and Fatigue in Young Adults with Juvenile Idiopathic Arthritis – Based on A Nordic Prospective Longitudinal Study" in 2020, establishing her expertise in this specialized area of pediatric rheumatology.
Anders Hjort is a Doctoral Research Fellow (now PhD graduate) at the University of Oslo's Department of Mathematics within the Statistics and Data Science group. He successfully defended his PhD dissertation in February 2025, focusing on uncertainty quantification in house price prediction using machine learning techniques. His work bridges academic research and industry applications through collaboration with Eiendomsverdi, a Norwegian property technology company. His educational background includes a Master of Science in Industrial Mathematics from the Norwegian University of Science and Technology (NTNU) in Trondheim (2019), complemented by one academic year at Technische Universität Berlin. Prior to his PhD, he worked as a consultant for Deloitte. Hjort's research centers on tree-based machine learning methods, conformal prediction, and computational statistics for real estate valuation. He specializes in developing interpretable models that quantify prediction uncertainty, particularly for automated valuation systems in housing markets. His approach combines statistical rigor with practical machine learning applications to address challenges in property technology. His publication record reveals a consistent trajectory in applying conformal prediction and interpretable AI to housing market analysis. The research spans theoretical uncertainty quantification frameworks to empirical studies of Norwegian and international markets, often utilizing locally weighted methods and ensemble tree models. This work demonstrates increasing sophistication in handling spatial heterogeneity and model confidence in real estate prediction. Hjort has actively engaged with the academic community through conference presentations at COPA and WEAI events, participation in the Machine Learning Summer School near Cape Town, and a visiting researcher position at North Carolina State University's Statistics Department in fall 2023. His PhD project (2021-2024) was supervised by Associate Professors Johan Pensar and Ida Scheel, and Professor Dag Einar Sommervoll from NMBU.
Jens Petter Berg serves as the Vice-Rector for Life Sciences and Health Research at the University of Oslo (2025-) and is a Professor at the Institute of Clinical Medicine. With extensive leadership experience, he previously served as Dean of Research at the Faculty of Medicine (2019-2022) and has been instrumental in establishing the Centre for Pandemics and One-Health Research. Berg holds a cand. med. (1995) and dr. med. (2004) from the University of Oslo and is a specialist in medical biochemistry. His academic career includes multiple leadership roles: Professor of Medicine (Clinical Biochemistry) at UiO since October 2007 Senior consultant (20%) at the Department of Medical Biochemistry, Oslo University Hospital Head of Research at SUSTAINIT, UiO (March 2024-May 2025) Acting Head of Center for Pandemics and One-Health Research (January 2023-February 2024) Head of Education in Clinical Biochemistry (October 2016-December 2018) Head of Department of Medical Biochemistry (October 2015-January 2019) Berg's research focuses on biochemical and hormonal changes in endocrine diseases, particularly pituitary tumors and diabetes, as well as One-Health and sustainable solutions for health and life sciences. His work bridges clinical practice with molecular and biochemical investigations to understand disease mechanisms and improve diagnostic and therapeutic approaches. His recent publications demonstrate a strong focus on endocrine disorders, particularly pituitary tumors and diabetes. The research spans from basic molecular mechanisms to clinical applications, with a growing emphasis on population health and multi-ethnic studies. His work often involves interdisciplinary collaboration across medicine, biochemistry, and public health. Berg holds several important positions in national and international organizations: Board member of Inven2 (2025-) Board member of Norway Health Tech (2025-) Member of The Directorate of Health's National Council for Diabetes Member of The Research Council of Norway's reference group for health in Horizon Europe Managing editor of Scandinavian Journal of Clinical and Laboratory Investigation (since 2010) Throughout his career, Berg has demonstrated leadership in research administration and has been involved in numerous collaborative projects between the University of Oslo and university hospitals. His work has contributed significantly to understanding biomarkers in endocrine diseases and developing sustainable health solutions through the One-Health approach. Berg is actively involved in several research groups including the Biochemical Endocrinology and Metabolism group and The Blood Cell Research Group at the University of Oslo.
Kristian Tonby is an Associate Professor at the University of Oslo , affiliated with the Department of Infectious Diseases . His work focuses on immunological responses in Tuberculosis (TB) and SARS-CoV-2 infections, with an emphasis on biomarker discovery, host-pathogen interactions, and adjunctive therapies. Key Roles : Researcher in infectious diseases, co-author in high-impact clinical trials, and member of the Chronic Infections (CIRG) research group. Projects : Involved in the COLONIZE study on intestinal microbiota transplantation for Clostridioides difficile infections and the NOR-Solidarity trial for severe COVID-19. Research Interests include: Immunological profiling in TB and HIV co-infection Impact of anti-inflammatory drugs on infectious disease outcomes Gut microbiome in infectious disease prognosis Cytokine dynamics in severe viral and bacterial infections Development of plasma biosignatures for diagnostics Machine learning applications in mortality prediction Selected Publication Trends : 2021–2025: Multinational trials on baricitinib for severe COVID-19 2020–2024: Biomarker studies on gut microbiota, complement activation, and chemokines in SARS-CoV-2 2015–2021: TB vaccine trials (H56:IC31) and COX-2 inhibitor effects on mycobacterial immunity Kristian Tonby's work bridges clinical research, immunology, and translational studies in infectious diseases , with ongoing collaborations across immunology, microbiology, and critical care medicine.
Professor Frank Narve Rosell is a distinguished researcher at the University of South-Eastern Norway, where he serves in the Institute for Nature, Health and the Environment within the Faculty of Technology, Natural Sciences and Maritime Studies. Based at the Bø campus, he has established himself as a leading expert in behavioral ecology, particularly in the chemical communication systems of mammals. With a Dr.scient (PhD) in Zoology from NTNU (2002), an MSc in Zoology (1994), and a Bachelor's in Chemical Engineering (Biotechnology) from Høgskolen i Østfold (1991), Professor Rosell brings a unique interdisciplinary perspective to his work. His educational background in both biology and engineering informs his methodological approach to wildlife research. Professor Rosell's research primarily focuses on the behavioral ecology of Eurasian beavers (Castor fiber), with a continuous long-term study spanning over 25 years since 1997. He has live-trapped and studied nearly 600 individual beavers, collecting data from over 1,500 trappings. His work examines scent marking behavior, territoriality, and the ecological impact of beavers as 'ecosystem engineers.' Complementing this, he has made significant contributions to understanding canine olfaction, authoring the internationally recognized book 'Secrets of the Snout: The Dog's Incredible Nose.' Analysis of his recent publications reveals a consistent focus on innovative wildlife monitoring techniques, beaver ecology, and conservation applications. His work spans from fundamental behavioral studies to practical conservation solutions, with increasing emphasis on non-invasive monitoring methods and interdisciplinary approaches to wildlife management. Nomination to Dog Writers Association of America 2018 Annual Writing Competition for 'Secrets of the Snout: The Dog's Incredible Nose' Recognized as the most productive beaver researcher in the world in 2018 Extensive publication record including 148 scientific papers and multiple books Professor Rosell has supervised 13 PhD students, 56 Master's students, and 49 Bachelor's students to completion. His current research is supported by multiple grants from Norwegian funding agencies including the Norwegian Food Safety Authority, Norwegian Environment Agency, and NFR. His work combines long-term ecological monitoring with innovative approaches to wildlife conservation, maintaining a strong connection between fundamental research and practical applications. Leading the Norwegian Beaver Project, Professor Rosell's research team employs advanced techniques including bio-logging, camera trapping, and chemical analysis to understand beaver behavior and ecology. His work has direct applications to wildlife management and conservation policy, reflecting his commitment to ensuring research informs practical conservation efforts.
Jerzy Norbert Nykiel serves as Associate Professor in the Department of Foreign Languages within the Faculty of Humanities at University of Bergen. His academic profile centers on rigorous historical linguistic research with particular emphasis on syntactic evolution in English across multiple historical periods. Professor Nykiel's research program systematically investigates grammaticalization pathways and syntactic change through corpus-driven methodologies. Key areas include: Development of progressive constructions and alternative aspectual markers Evolution of prepositional phrases into subordinators Negation patterns and idiomatic expression change Copula systems and adjunct structures in historical English His work bridges Germanic and Romance linguistics through comparative frameworks, as demonstrated in the 2025 edited volume examining progressive aspect across language families. Analysis of his recent publications (2020-2025) reveals consistent output focused on diachronic syntax, with increasing attention to quantitative corpus methods. The research demonstrates strong continuity in examining grammaticalization cycles while expanding into cross-linguistic comparisons, particularly between Germanic and Romance language systems. Professor Nykiel maintains active scholarly engagement through conference presentations and collaborative projects, including co-authored works with international researchers like Kristian A. Rusten and Reijirou Shibasaki. His role as co-editor of the 2025 John Benjamins anthology confirms leadership in the field of historical linguistics.
Hanne Sørum serves as an Associate Professor at Kristiania University of Applied Sciences within the School of Economics, Innovation and Technology, where she delivers instruction in interaction design and effect evaluation methodologies while overseeing bachelor project coordination for technology-focused curricula. Her academic responsibilities integrate pedagogical leadership with practical application in digital innovation domains. Her research portfolio demonstrates concentrated expertise in information systems infrastructure, human-computer interaction frameworks, and eGovernment service optimization, complemented by specialized skills in interaction design prototyping and empirical user testing protocols. These interconnected fields reflect a strategic commitment to advancing user-centered digital solutions across public and private sectors through rigorous evaluation practices. As an academic supervisor, Dr. Sørum provides dedicated mentorship for bachelor and master students during thesis development and research execution, cultivating next-generation expertise in technology design and evaluation through personalized guidance and methodological training.
